On June 29, the U.S. Supreme Court ruled to end race-conscious college admissions. In reaction to the Court’s ruling, and its potential effect on reversing progress toward increasing diversity in the nation’s physician workforce, ASCO released the following statement from Chief Executive Officer Clifford A. Hudis, MD, FACP, FASCO, via Twitter:
“Today’s U.S. Supreme Court ruling on affirmative action threatens to reverse hard-won gains in diversity across medicine, including oncology. The country needs a pipeline of diverse oncology professionals to reach all patients, help eliminate significant health disparities, and enable all of us to achieve optimal health outcomes. ASCO will continue advocating for an oncology workforce that reflects the lives and experiences of those in treatment, and our commitment is stronger than ever.”The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.